ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PSTX Poseida Therapeutics Inc

2.00
-0.04 (-1.96%)
Apr 18 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Poseida Therapeutics Inc PSTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.04 -1.96% 2.00 18:08:20
Open Price Low Price High Price Close Price Prev Close
2.05 2.00 2.16 2.00 2.04
more quote information »

Recent News

Date Time Source Heading
4/18/202408:00PRNUSPoseida Therapeutics Announces Strong Lineup of..
4/17/202409:00PRNUSPoseida Therapeutics Hosts Gene Therapy R&D Day Highlighting..
4/08/202412:00PRNUSPoseida Therapeutics Presents New Phase 1 Data at AACR 2024..
4/01/202416:05PRNUSPoseida Therapeutics Announces Inducement Grant Under Nasdaq..
3/25/202416:05PRNUSPoseida Therapeutics Appoints Syed Rizvi, M.D., as Chief..
3/19/202416:05PRNUSPoseida Therapeutics to Present at H.C. Wainwright 2nd..
3/13/202416:05PRNUSPoseida Therapeutics Announces FDA Orphan Drug Designation..
3/07/202416:07PRNUSPoseida Therapeutics Provides Updates and Financial Results..
3/07/202416:05EDGAR2Form 8-K - Current report
3/04/202417:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202417:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202416:05PRNUSPoseida Therapeutics Announces Inducement Grant Under Nasdaq..
2/08/202416:10EDGAR2Form S-8 - Securities to be offered to employees in employee..
1/04/202416:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
1/04/202416:01EDGAR2Form 8-K - Current report
1/04/202408:00PRNUSPoseida Therapeutics Highlights Recent Progress, Strategic..
12/11/202310:31DJNPoseida Therapeutics Shares Climb on Positive Data for Blood..
12/11/202306:06EDGAR2Form 8-K - Current report
12/10/202312:00PRNUSPoseida Therapeutics Presents Positive Early Results from..
11/09/202316:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202316:05EDGAR2Form 8-K - Current report
11/09/202316:05PRNUSPoseida Therapeutics Provides Updates and Financial Results..
11/07/202308:00PRNUSPoseida Therapeutics to Present at Two Upcoming Investor..
11/02/202309:01PRNUSPoseida Therapeutics to Present at the 65th ASH Annual..
10/09/202316:30PRNUSPoseida Therapeutics Announces Leadership Transition
9/05/202308:00PRNUSPoseida Therapeutics to Present at Two Upcoming Investor..
8/14/202316:41EDGAR2Form SC 13D - General statement of acquisition of beneficial..
8/11/202316:48EDGAR2Form D - Notice of Exempt Offering of Securities
8/08/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/202316:06EDGAR2Form 8-K - Current report
8/08/202316:05PRNUSPoseida Therapeutics Provides Financial Results for the..
8/07/202310:41DJNPoseida Therapeutics Shares Leap on Astellas Investments
8/07/202309:58DJNPoseida Therapeutics in $50 Million Investment Deal With..
8/07/202309:01EDGAR2Form 8-K - Current report
8/07/202309:01PRNUSPoseida Therapeutics Announces Strategic Investment by..
8/07/202309:00PRNUSAstellas and Poseida Therapeutics Announce Strategic..
7/05/202308:00PRNUSPoseida Therapeutics Announces FDA Clearance of..
6/26/202308:00PRNUSPoseida Therapeutics to Join Russell 3000® and Russell 2000®..
6/01/202308:00PRNUSPoseida Therapeutics Announces Virtual 2023 Annual Meeting..
5/23/202308:00PRNUSPoseida Therapeutics to Present at Stifel 2023 Tailoring..
5/22/202308:00PRNUSPoseida Therapeutics to Present at 31st Congress of the..
5/18/202308:00PRNUSPoseida Therapeutics Presents Encouraging Preclinical Data..
5/09/202316:05PRNUSPoseida Therapeutics Provides Updates and Financial Results..
5/02/202316:30PRNUSPoseida Therapeutics Announces Multiple Presentations at the..
5/01/202308:00PRNUSPoseida Therapeutics to Present at BofA Securities 2023..

Your Recent History

Delayed Upgrade Clock